Deepika Malik
NPI 1134530306 · Retina Specialist (Ophthalmology) Physician · Woodbury, NY
Enrolled with Medicare as Practitioner - Ophthalmology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1134530306
- Entity type
- Individual
- Primary specialty
- Retina Specialist (Ophthalmology) PhysicianAllopathic & Osteopathic Physicians
- Sex
- Female
- Sole proprietor
- No
- License
- 316968 (NY)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
12 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
6,341 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Imaging of Retina92134 | 1,454 | $45 |
| Injection of Drug Into Eye67028 | 1,211 | $140 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 | 976 | $145 |
| Photography of the Retina92250 | 886 | $41 |
| Established Patient Complete Exam of Visual System92014 | 765 | $141 |
| Exam of Retinal Blood Vessels Using a Special Camera After Injection of a Dye92235 | 281 | $187 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 15 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Prednisolone Acetate | 312 | 182 |
| Atropine Sulfate | 133 | 110 |
| Moxifloxacin Hclbrand: Moxifloxacin | 122 | 99 |
| Dorzolamide Hcl/Timolol Maleatbrand: Dorzolamide-Timolol | 71 | 43 |
| Ketorolac Tromethamine | 53 | 33 |
| Latanoprost | 46 | 14 |
| Neomycin/Polymyxin B/Dexamethabrand: Neomycin-Polymyxin-Dexameth | 41 | 30 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$61,825 across 109 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2014-05-09
- Last updated
- 2024-07-26
- Certified
- 2023-12-28
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.